We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares

Delisted

HZNP was delisted on the 5th of October, 2023.

6 hedge funds and large institutions have $49.4K invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 474 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 4856 (-479)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 474

100% less funds holding in top 10

Funds holding in top 10: 800 (-80)

100% less capital invested

Capital invested by funds: $24.8B → $49.4K (-$24.8B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-479
Holders Change %
-98.76%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
-80
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
1
Closed
474
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TD Asset Management
226
TD Asset Management
Ontario, Canada
-$3.7M -31,961 Closed
X
227
Xponance
Pennsylvania
-$3.37M -29,120 Closed
KOCAA
228
Knights of Columbus Asset Advisors
Connecticut
-$3.26M -28,204 Closed
Wealthfront Advisers
229
Wealthfront Advisers
California
-$3.22M -27,860 Closed
Royal Bank of Canada
230
Royal Bank of Canada
Ontario, Canada
-$3.14M -27,155 Closed
AM
231
AGF Management
Ontario, Canada
-$3.13M -27,085 Closed
American Century Companies
232
American Century Companies
Missouri
-$3.13M -27,061 Closed
Group One Trading
233
Group One Trading
Illinois
-$2.99M -25,845 Closed
AB
234
Amalgamated Bank
New York
-$2.97M -25,658 Closed
AA
235
AlphaCentric Advisors
Puerto Rico
-$2.95M -25,500 Closed
Public Employees Retirement Association of Colorado
236
Public Employees Retirement Association of Colorado
Colorado
-$2.93M -25,321 Closed
Legal & General Group
237
Legal & General Group
United Kingdom
-$2.9M -25,059 Closed
TCA
238
Troluce Capital Advisors
Puerto Rico
-$2.89M -25,002 Closed
SC
239
Shay Capital
New York
-$2.89M -25,000 Closed
Commonwealth Equity Services
240
Commonwealth Equity Services
Massachusetts
-$2.89M -24,946 Closed
KCM
241
Kornitzer Capital Management
Kansas
-$2.86M -24,700 Closed
GCM
242
Greenland Capital Management
New York
-$2.75M -23,738 Closed
Connor, Clark & Lunn Investment Management (CC&L)
243
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.72M -23,498 Closed
NAM
244
Nissay Asset Management
Japan
-$2.72M -23,490 Closed
VPIM
245
Vanguard Personalized Indexing Management
California
-$2.58M -22,313 Closed
OPERF
246
Oregon Public Employees Retirement Fund
Oregon
-$2.52M -21,790 Closed
SC
247
Searle & Co
Connecticut
-$2.47M -21,350 Closed
ProShare Advisors
248
ProShare Advisors
Maryland
-$2.42M -20,933 Closed
KBC Group
249
KBC Group
Belgium
-$2.4M -20,794 Closed
GIBU
250
Gulf International Bank (UK)
United Kingdom
-$2.32M -20,020 Closed

HZNP Hedge Fund Activity: Q4 2023 in Review

6 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q4 2023, worth a combined $49.4K — down 100% from $24.8B a quarter earlier.

Sellers outnumbered buyers: 474 funds closed out of HZNP and 2 opened new positions — a net loss of 472 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $4.88K. The largest seller was Vanguard Group, exiting entirely with an estimated $2.5B sold.

  • 6 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q4 2023, down from 485 in Q3 2023.
  • Funds reported $49.4K of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q4 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q4 2023 and 474 closed out, a net change of -472 holders.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q4 2023 was Blue Trust Inc, an estimated $4.88K added.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q4 2023 was Vanguard Group, an estimated $2.5B sold.

Based on aggregated 13F filings for Q4 2023.